Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1189294.RAZoN6lmdzDSOJ4HHcu7M5B3xQBaK7s0bfPWD_xGyRGmQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1189294.RAZoN6lmdzDSOJ4HHcu7M5B3xQBaK7s0bfPWD_xGyRGmQ130_assertion type Assertion NP1189294.RAZoN6lmdzDSOJ4HHcu7M5B3xQBaK7s0bfPWD_xGyRGmQ130_head.
- NP1189294.RAZoN6lmdzDSOJ4HHcu7M5B3xQBaK7s0bfPWD_xGyRGmQ130_assertion description "[Further prospective studies in additional patients with mutations in GRIN2A will be required to optimize seizure management for this rare disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1189294.RAZoN6lmdzDSOJ4HHcu7M5B3xQBaK7s0bfPWD_xGyRGmQ130_provenance.
- NP1189294.RAZoN6lmdzDSOJ4HHcu7M5B3xQBaK7s0bfPWD_xGyRGmQ130_assertion evidence source_evidence_literature NP1189294.RAZoN6lmdzDSOJ4HHcu7M5B3xQBaK7s0bfPWD_xGyRGmQ130_provenance.
- NP1189294.RAZoN6lmdzDSOJ4HHcu7M5B3xQBaK7s0bfPWD_xGyRGmQ130_assertion SIO_000772 24903190 NP1189294.RAZoN6lmdzDSOJ4HHcu7M5B3xQBaK7s0bfPWD_xGyRGmQ130_provenance.
- NP1189294.RAZoN6lmdzDSOJ4HHcu7M5B3xQBaK7s0bfPWD_xGyRGmQ130_assertion wasDerivedFrom befree-2016 NP1189294.RAZoN6lmdzDSOJ4HHcu7M5B3xQBaK7s0bfPWD_xGyRGmQ130_provenance.
- NP1189294.RAZoN6lmdzDSOJ4HHcu7M5B3xQBaK7s0bfPWD_xGyRGmQ130_assertion wasGeneratedBy ECO_0000203 NP1189294.RAZoN6lmdzDSOJ4HHcu7M5B3xQBaK7s0bfPWD_xGyRGmQ130_provenance.